ArticleFrontiers in aging neuroscience2025
Hippocampal T1WI radiomics- and clinical feature-based models for predicting early mild cognitive impairment in secondary hydrocephalus.
Article in Frontiers in aging neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Mild cognitive impairment (MCI) represents the initial stage of dementia, and early diagnosis is crucial in clinical practice. This study aimed to investigate the predictive performance of three models based on clinical features, radiomics features of hippocampal T1-weighted imaging, and a combination of these features for identifying MCI in patients with secondary hydrocephalus. Methods: Of the 378 patients with secondary hydrocephalus, 124 were ultimately included in the study and divided into two cohorts: those with Mild Cognitive Impairment (MCI, Results: In the clinical model, the disease course, serum uric acid, serum cystatin C, and the lateral ventricular temporal horn ratio emerged as independent risk factors for MCI following hydrocephalus. In the radiomics model, four optimal hippocampal features were identified. The AUC values for the clinical, radiomics, and combined models in the training/validation sets were 0.827 (0.736 ~ 0.919)/0.812 (0.666 ~ 0.957), 0.864 (0.790 ~ 0.937)/0.849 (0.724 ~ 0.974), and 0.937 (0.889 ~ 0.985)/0.907 (0.804 ~ 1.000), respectively. The combined model exhibited higher AUC values than the MoCA scale in both datasets. There was a significant difference in the training set, and while the validation set showed a consistent trend, it did not achieve statistical significance. Conclusion: The combined model achieved optimal performance and demonstrated superior predictive capabilities for MCI in the patients with secondary hydrocephalus outperforming other models.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.